Skip to the page

Data / Form D filings / Kylin Therapeutics Inc

Kylin Therapeutics Inc: Form D filing

Kylin Therapeutics Inc, a biotechnology company in West Lafayette, IN, filed a Form D with the SEC in 2009. The latest, on November 23, 2009, reports $57,896 sold of a $2 million offering to 2 investors.

Find out what Kylin Therapeutics Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3000 Kent Avenue, West Lafayette, IN, 47906
Phone
(765) 412-6661
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Indiana
Year incorporated
2006
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1418644

The full lists. Form D filings in Indiana: 436 rows, $21.80, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 23, 2009New notice$2,000,000$57,896$1,942,1042Nov 9, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Christopher Eric MeldrumExecutive Officer, Director
J. Eric DavisExecutive Officer, Director
Homer Eric PearceDirector
Joseph Eric TrebleyExecutive Officer

Other biotechnology companies in Indiana that filed recently

Every Form D from the week of Nov 23, 2009 · All recent filings in Indiana · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Kylin Therapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.